Title: "Ex-Vivo Modeling for Heritability Assessment and Genetic Mapping in Pharmacogenomics"
Speaker: Alison Motsinger-Reif, Department of Statistics, North Carolina State University, Raleigh, NC
Place: HORT 117; November 1, 2011, Tuesday, 4:30pm


The investigation of genetic factors that determine differential drug response is a key goal of pharmacogenomics (PGX), and relies on the often-untested assumption that differential response is heritable. While limitations in traditional study design often prohibit heritability (h2) estimates in PGX, new approaches may allow such estimates. We demonstrate an ex vivo model system to determine the h2 of drug-induced cell killing and performed genome-wide analysis for gene mapping. The cytotoxic effect of 29 diverse chemotherapeutic agents on lymphoblastoid cell lines (LCLs) derived from family- and population-based cohorts was investigated. We used a high throughput format to determine cytotoxicity of the drugs on LCLs and developed a new evolutionary computation approach to fit response curves for each individual. Variance components analysis determined the h2 for each drug response and a wide range of values was observed across drugs. Genome-wide analysis was performed using new analytical approaches. These results lay the groundwork for future studies to uncover genes influencing chemotherapeutic response and demonstrate a new computational framework for performing such analysis.

Click here www.stat.purdue.edu/~doerge/BIOINFORM.D/FALL11/sem.html for a full schedule of BIOINFORMATICS SEMINARS, past and present.